Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Bodewell Products for the Treatment of Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Bodewell Products in Atopic Dermatitis; the study led by the University of Alabama at Birmingham is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bodewell Products

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Atopic Dermatitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING